| miRNAs | value | Up-/downregulation | Predicted function in neurogenesis | mRNA targets | Functional significance |
| miRNA503 | 0.003 | 1.35 times | transition of quiescence-to-proliferation stage | Cdk2/Cdc25A | [10] |
| miRNA433 | 0.002 | 1.68 times | Neural development proliferation/self-renewal-to-differentiation | ERRG, NR0B2 or SHP-1, RISC, EIF2, Ago2, edaravone, and hydroxypropyl-beta-cyclodextrin | [11ā13] |
| miRNA143 | 0.002 | 2.56 times | Proliferation, neural differentiation, and survival | PDGFRA, PRKCE, MAPK7, DSSP, DMP-1, KRAS, and BCL-2 | [14, 15] |
| miRNA326 | 0.0002 | 1.58 times | Maintenance and survival of striatal precursor pool | TGM7 | [16, 17] |
| miRNA181c | 0.0029 | 1.50 times | Switch for lineage-to-self-renewal and telomerase expression | PTPN11, PTPN22, DUSP6, PBX3, IRF8, and ZEB2 | [18ā21] |
| miRNA22 | 0.001 | 1.22 times | Proliferation and apoptosis | HDAC4, RCOR1, RGS2, MAPK14/p38, Tp53inp1, and P38 MAPK | [22, 23] |
|
|